A phase 2 study of brentuximab vedotin in combination with pembrolizumab in subjects with metastatic solid malignancies
Categories (click each to see list of all clinical trials associated with that category): Head & Neck (ONC), Thoracic (ONC)
Current Status: Open
Phase: II (Cancer Control)
Principal Investigator: Abughanimeh, Omar
Eligibility: https://clinicaltrials.gov/study/NCT04609566?term=%09NCT04609566&rank=1
Summary
Evaluate the objective response rate (ORR) of the combination of brentuximab vedotin with pembrolizumab